KLP Kapitalforvaltning AS Takes $194,000 Position in Alignment Healthcare, Inc. (NASDAQ:ALHC)

KLP Kapitalforvaltning AS purchased a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 17,200 shares of the company’s stock, valued at approximately $194,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. R Squared Ltd bought a new stake in shares of Alignment Healthcare during the fourth quarter worth $55,000. Ballentine Partners LLC bought a new position in shares of Alignment Healthcare in the 4th quarter valued at $121,000. Aigen Investment Management LP acquired a new stake in shares of Alignment Healthcare during the 4th quarter valued at $129,000. AlphaQuest LLC bought a new stake in Alignment Healthcare during the 4th quarter worth $132,000. Finally, Proficio Capital Partners LLC bought a new stake in Alignment Healthcare during the 4th quarter worth $184,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $17.82 on Tuesday. The company has a market capitalization of $3.42 billion, a PE ratio of -23.14 and a beta of 1.32. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a twelve month low of $4.62 and a twelve month high of $18.97. The firm has a fifty day simple moving average of $15.69 and a 200 day simple moving average of $13.29.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Stifel Nicolaus lifted their price target on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, February 28th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Stephens restated an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research report on Monday, February 24th. Piper Sandler lifted their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, March 4th. Finally, Barclays increased their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average target price of $14.83.

Insiders Place Their Bets

In related news, insider Andreas P. Wagner sold 14,878 shares of the firm’s stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total transaction of $213,945.64. Following the completion of the sale, the insider now owns 200,885 shares of the company’s stock, valued at $2,888,726.30. This trade represents a 6.90 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $13.61, for a total value of $408,300.00. Following the completion of the transaction, the president now directly owns 1,606,097 shares in the company, valued at approximately $21,858,980.17. This trade represents a 1.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,981,855 shares of company stock worth $30,590,612. Company insiders own 6.60% of the company’s stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.